Fever of unknown origin surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 4: Line 4:


==Overview==
==Overview==
Surgical intervention is not recommended for the management of [disease name].
Currently there are no guidelines for surgical treatment of FUO, Medical management is the mainstay of treatment for FUO.<ref name="KayaErgul2014">{{cite journal|last1=Kaya|first1=Abdurrahman|last2=Ergul|first2=Nurhan|last3=Kaya|first3=Sibel Yildiz|last4=Kilic|first4=Fahrettin|last5=Yilmaz|first5=Mehmet Halit|last6=Besirli|first6=Kazim|last7=Ozaras|first7=Resat|title=The management and the diagnosis of fever of unknown origin|journal=Expert Review of Anti-infective Therapy|volume=11|issue=8|year=2014|pages=805–815|issn=1478-7210|doi=10.1586/14787210.2013.814436}}</ref>
 
OR
 
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
 
OR
 
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
 
OR
 
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
 
OR
 
Surgery is the mainstay of treatment for [disease or malignancy].


==Indications==
==Indications==
 
Currently there are no guidelines for surgical treatment of FUO, Medical management is the mainstay of treatment for FUO.
*Surgical intervention is not recommended for the management of [disease name].
OR
*Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
**[Indication 1]
**[Indication 2]
**[Indication 3]
 
==Surgery==
 
*The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
*Surgery is the mainstay of treatment for [disease or malignancy].
 
==Contraindications==


==References==
==References==

Latest revision as of 20:24, 10 February 2021

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fever of unknown origin surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fever of unknown origin surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fever of unknown origin surgery

CDC on Fever of unknown origin surgery

Fever of unknown origin surgery in the news

Blogs on Fever of unknown origin surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Fever of unknown origin surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Currently there are no guidelines for surgical treatment of FUO, Medical management is the mainstay of treatment for FUO.[1]

Indications

Currently there are no guidelines for surgical treatment of FUO, Medical management is the mainstay of treatment for FUO.

References

  1. Kaya, Abdurrahman; Ergul, Nurhan; Kaya, Sibel Yildiz; Kilic, Fahrettin; Yilmaz, Mehmet Halit; Besirli, Kazim; Ozaras, Resat (2014). "The management and the diagnosis of fever of unknown origin". Expert Review of Anti-infective Therapy. 11 (8): 805–815. doi:10.1586/14787210.2013.814436. ISSN 1478-7210.

Template:WH Template:WS